| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10910825 | Lung Cancer | 2015 | 7 Pages |
Abstract
Evaluation of SNPs in CYP3A5 and CYP2D6 can effectively predict severe hepatotoxicity induced by gefitinib. Erlotinib can be used as an alternative treatment for patients who develop gefitinib-induced severe hepatotoxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Eri Sugiyama, Shigeki Umemura, Shogo Nomura, Keisuke Kirita, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Hironobu Ohmatsu, Masahiro Tsuboi, Yuichiro Ohe, Koichi Goto,